A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types

Yoav Ben-Simon,Marcus Hooper,Sujatha Narayan,Tanya L Daigle,Deepanjali Dwivedi,Sharon W Way,Aaron Oster,David A Stafford,John K Mich,Michael J Taormina,Refugio A Martinez,Ximena Opitz-Araya,Jada R Roth,Shona Allen,Angela Ayala,Trygve E Bakken,Tyler Barcelli,Stuard Barta,Jacqueline L Bendrick,Darren Bertagnolli,Jessica Bowlus,Gabriella Boyer,Krissy Brouner,Brittny Casian,Tamara Casper,Anish B Chakka,Rushil Chakrabarty,Rebecca K Chance,Sakshi Chavan,Michael Clark,Maxwell Departee,Nicholas Donadio,Nadezhda Dotson,Tom Egdorf,Mariano Gabitto,Jazmin Garcia,Amanda Gary,Molly Gasperini,Jessica Gloe,Jeff Goldy,Bryan B Gore,Lucas Graybuck,Noah Greisman,Francoise Haeseleer,Carliana Halterman,Olivia Helback,Windy Ho,Dirk Hockemeyer,Cindy Huang,Sydney Huff,Avery Hunker,Nelson Johansen,Zoe Juneau,Brian Kalmbach,Madhav Kannan,Shannon Khem,Emily Kussick,Rana Kutsal,Rachael Larsen,Changkyu Lee,Angus Y Lee,Madison Leibly,Garreck H Lenz,Elizabeth Liang,Nicholas Lusk,Jocelin Malone,Rachel McCue,Tyler Mollenkopf,Elyse Morin,Dakota Newman,Lydia Ng,Kiet Ngo,Victoria Omstead,Alana Oyama,Trangthanh Pham,Elliot Phillips,Christina A Pom,Lydia Potekhina,Shea Ransford,Dean Rette,Christine Rimorin,Dana Rocha,Augustin Ruiz,Raymond E.A Sanchez,Adriana Sedeno-Cortes,Joshua P Sevigny,Nadiya Shapovalova,Lyudmila Shulga,Ana R Sigler,La Siverts,Saroja Somasundaram,Kaiya Stewart,Eric Szelenyi,Michael Tieu,Cameron Trader,Alex Tran,Cindy T.J van Velthoven,Miranda Walker,Natalie Weed,Morgan E Wirthlin,Toren Wood,Brooke Wynalda,Zizhen Yao,Thomas Zhou,Jeanelle Ariza,Nick Dee,Melissa Reding,Kara Ronellenfitch,Shoaib Mufti,Susan M Sunkin,Kimberly A Smith,Luke Esposito,Jack Waters,Bargavi Thyagarajan,Shenqin Yao,Ed Lein,Hongkui Zeng,Boaz P Levi,John Ngai,Jonathan T Ting,Bosiljka Tasic

DOI: https://doi.org/10.1101/2024.06.10.597244

2024-09-27

Abstract:The mammalian cortex is comprised of cells classified into types according to shared properties. Defining the contribution of each cell type to the processes guided by the cortex is essential for understanding its function in health and disease. We used transcriptomic and epigenomic cortical cell type taxonomies from mouse and human to define marker genes and putative enhancers and created a large toolkit of transgenic lines and enhancer AAVs for selective targeting of cortical cell populations. We report evaluation of fifteen new transgenic driver lines, two new reporter lines, and >800 different enhancer AAVs covering most subclasses of cortical cells. The tools reported here as well as the scaled process of tool creation and modification enable diverse experimental strategies towards understanding mammalian cortex and brain function.

Neuroscience

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to achieve precise genetic access to cell types in the mammalian cerebral cortex. Specifically, researchers used transcriptomics and epigenetics data to define the classification of cell types in the mouse and human cerebral cortex, and based on these classifications, developed a series of enhancer - AAV (Adeno - Associated Virus) and transgenic mouse strains to achieve selective targeting of specific cortical cell populations. Through this method, researchers hope to improve the precision of operating on specific cell types in experiments, thereby better understanding the functions of the cerebral cortex in healthy and diseased states.

The main contributions of the paper include:
1. **Creation of a set of tools**: including 15 new transgenic driver strains, 2 new reporter gene strains, and more than 800 different enhancer - AAVs, covering most cortical cell sub - classes.
2. **Evaluation of tool effectiveness**: Through fluorescence imaging, single - cell RNA sequencing, etc., the performance of these tools in selectively marking specific cell types was evaluated in detail.
3. **Optimization of tool performance**: By "bashing" and tandem of the enhancer core regions, the expression intensity and specificity of some enhancer - AAVs were improved.
4. **Expansion of tool application range**: Replacing fluorescent proteins with Cre recombinase enables these tools to be combined with existing or new Cre - dependent AAVs or mouse transgenes, further increasing the flexibility and application range of the tools.

Through these works, researchers not only provide valuable tool resources for neuroscience research but also lay the foundation for understanding the functions of the cerebral cortex and its role in diseases.